Envista Holdings Corp. 10-Q Summary: Q1 2026
Business Context and Reporting Period
This report covers the quarterly period ended April 3, 2026. Envista Holdings Corp. is a global provider of dental products, equipment, and services, operating in two segments: Specialty Products & Technologies (implants, orthodontics, aligners) and Equipment & Consumables (digital imaging, restorative materials, infection prevention). The company reported strong growth driven by volume, pricing, and favorable foreign exchange rates, partially offset by tariff impacts and lower demand in China.
Key Financial Metrics
| Metric ($ in millions) | Q1 2026 | Q1 2025 |
|---|---|---|
| Sales | $705.5 | $616.9 |
| Gross Profit | $390.1 | $336.0 |
| Gross Margin | 55.3% | 54.5% |
| Operating Profit | $62.5 | $39.0 |
| Net Income | $38.7 | $18.0 |
| Diluted EPS | $0.23 | $0.10 |
| Operating Cash Flow | ($3.3) | $0.3 |
| Cash & Equivalents | $1,082.8 | $1,077.3 |
| Total Debt | $1,439.1 | $1,448.3 |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 14.4% year-over-year. Core sales (excluding acquisitions and currency) grew 9.5%, driven by a 7.8% volume increase and 1.7% price increase.
- Profitability: Operating profit surged 60.3% to $62.5 million, with margins expanding to 8.9% from 6.3%. Net income more than doubled to $38.7 million.
- Acquisition: The company acquired Versah LLC for approximately $54.7 million in cash to expand its implant and regenerative solutions portfolio. This added $20.2 million in goodwill.
- Cash Flow: Operating cash flow turned negative ($3.3 million used) compared to a slight positive in the prior year, primarily due to higher incentive compensation payments and working capital timing. Investing cash outflows increased significantly ($68.9 million) due to the Versah acquisition and higher capital expenditures.
- Foreign Exchange: A weaker U.S. dollar positively impacted reported sales by 4.3%.
Outlook, Risks, and Unusual Items
- Stock Repurchases: On May 5, 2026, the Board authorized a new $300 million stock repurchase program through December 31, 2029. During Q1, the company repurchased approximately $42.6 million of stock under the prior program.
- Tariffs and Trade: The company has experienced increased costs of sales due to U.S. import tariffs. While management expects to offset these via pricing and supply chain adjustments, future trade policy changes remain a risk.
- Geopolitical Risks: Ongoing conflicts in the Middle East (specifically involving Iran) and Russia-Ukraine tensions pose risks to supply chains, energy costs, and global economic stability.
- Legal Contingencies: The company has accrued $27.2 million for probable legal losses as of April 3, 2026. Management does not expect a material adverse effect on financial position, though resolution could impact future results.
- Tax Rate: The effective tax rate decreased to 25.9% from 37.9% in the prior year, attributed to the geographical mix of earnings and valuation allowances.
Investor Verification Checklist
- Core Sales Sustainability: Verify if the 9.5% core sales growth is sustainable given the offsetting impact of lower demand in China.
- Tariff Mitigation: Assess the company's ability to pass on tariff-related cost increases to customers without eroding volume.
- Operating Cash Flow: Monitor the reversal of the negative operating cash flow trend in subsequent quarters, specifically regarding working capital management.
- Acquisition Integration: Track the integration progress and revenue contribution of the Versah acquisition.
- Legal Accruals: Review updates on the $27.2 million legal accrual to ensure no significant increases in liability.